UniProtKB/Swiss-Prot Q9UQ84: Variant p.Pro757Leu

Exonuclease 1
Gene: EXO1
Feedback?

Variant information Variant position:

757 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Leucine (L) at position 757 (P757L, p.Pro757Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Most naturally occurring variants in this protein are not associated with familial disposition to hereditary non-polyposis colorectal cancer (HNPCC) (PubMed:12517792). Furthermore, germline deletions involving this locus are not associated with clinically manifested colorectal tumors (PubMed:14623461). Additional information on the polymorphism described.
Variant description:

May be associated with a reduced risk of colorectal cancer. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs9350 [ dbSNP | Ensembl ]

Sequence information Variant position:

757 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

846 The length of the canonical sequence.
Location on the sequence:

KVPGLYKSSSADSLSTTKIK P LGPARASGLSKKPASIQKRK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KVPGLYKSSSADSLSTTKIKPLGPARASGLSKKPASIQKRK

Mouse                         KVPGLCRSSSMDSFSTTKIKPLVPARVSGLSKKSGSMQTRK

Xenopus laevis                KVPGLLKSQSVVSGLRTKVKPRAPAKVSGLTNRSNTKATR-

Zebrafish                     KVSGLSRKGACGQGKGGKIETSAPARASGLRRKPSGKKNV-

Drosophila                    ----------------------------GLSKPSTAKKGTP

Slime mold                    NNDNNNKITTPSNKSFNSIVLTTTSATTSITQQDNEIYTTP

Baker's yeast                 ---------VIDMKSVDERKSFNSSPILHEESKKRDIETTK

Fission yeast                 --------------------PSSPSTPISMNPRPKGILS--

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 846	Exonuclease 1
Region	600 – 846	Interaction with MSH2
Region	618 – 781	Disordered
Modified residue	746 – 746	Phosphoserine

Literature citations
Human exonuclease I interacts with the mismatch repair protein hMSH2.
Schmutte C.; Marinescu R.C.; Sadoff M.M.; Guerrette S.; Overhauser J.; Fishel R.;
Cancer Res. 58:4537-4542(1998)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); INTERACTION WITH MSH2; TISSUE SPECIFICITY; VARIANTS ARG-354; LYS-589; GLY-670; CYS-723 AND LEU-757; Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ILE-76; GLY-93; SER-279; SER-299; ARG-354; ASN-428; MET-439; TYR-456; MET-458; LEU-460; THR-503; LYS-589; GLN-634; GLY-670; CYS-723; LEU-757 AND GLU-759; Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations.
Thompson E.; Meldrum C.J.; Crooks R.; McPhillips M.; Thomas L.; Spigelman A.D.; Scott R.J.;
Clin. Genet. 65:215-225(2004)
Cited for: VARIANTS MET-439; GLY-670; PRO-726 AND LEU-757; Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population.
Yamamoto H.; Hanafusa H.; Ouchida M.; Yano M.; Suzuki H.; Murakami M.; Aoe M.; Shimizu N.; Nakachi K.; Shimizu K.;
Carcinogenesis 26:411-416(2005)
Cited for: VARIANTS MET-439 AND LEU-757;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.